Results 131 to 140 of about 5,190,226 (209)

Hierarchical context enhancement for long-tail entity retrieval augmented generation. [PDF]

Front Artif Intell
Peng Y, Pan K.
europepmc   +1 more source

Advances in research on RNA methylation and its role in the immune microenvironment of gastrointestinal tumors. [PDF]

Front Cell Dev Biol
Duan Y, Xu Z, Wen K, Xue C, Shen R, Gu X.   +5 more
europepmc   +1 more source

A palmitoylation signature for prognosis immune infiltration and drug sensitivity in esophageal carcinoma. [PDF]

iScience
Xu C, Lu Z, Wu S, He Y, Peng X, Li Q, Gan W, Wu G, Wei G, Liu X, Ye C.   +10 more
europepmc   +1 more source

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer. [PDF]

Sci Rep
Lyu Y, Lyu H, Guo G, Zhao H, Lin W, Wang Y, Chen H, Huang Q, Xue F, Wang N, Lin J, Tian Y.   +11 more
europepmc   +1 more source

Integrative Analysis Uncovers <i>SETD5</i> as an Epigenetic Regulator of Transcriptional and Immune Tumor Programs Across Human Cancers. [PDF]

Curr Issues Mol Biol
Gualberto ACM, Santana BLO, de Loyola MB, da Costa YS, Pittella-Silva F.   +4 more
europepmc   +1 more source

A tumour-derived organoid biobank maps cancer gene dependencies. [PDF]

Nature
Herranz-Ors C, Bhosle SG, Beck AE, Gilbert JGR, Picco G, Espejo Valle-Inclan J, Muyas F, Valentini S, Andres AE, Ansari R, Barthorpe S, Battarbee G, Beaver CM, Brocklesby S, Cantwell J, Collins CA, Davis J, Dimitrova HG, Doran J, Efendi E, Evans K, Fekry M, Fowler TA, Garcia-Casado M, Griffiths JAT, Hall C, Hamer R, Hardy C, Hewitson Z, Hitch E, Holland L, Jackson DA, Joshi N, Kavasakali A, Letchford L, Lightfoot HB, Lingala H, Mali I, May K, Mironenko T, Morris J, Pacini C, Price S, Robert-Tissot G, Rogers HA, Smith JV, Smith K, Souster E, Spence WJ, Thomas F, Vieira SF, Walker S, Alfonsin G, Bermingham H, Coles H, Ennis DP, Freeman A, Giannone G, Grehan N, Griffiths EA, Hall J, Lee SL, Leung EYL, Loreno C, Millington C, Mirnezami A, Nutzinger B, Orzechowska K, Pinna CMA, Redmond AM, Roberts K, Roy S, Sanders DA, Taniere P, Vias M, Wanigasooriya K, OCCAMS Consortium, Stratton MR, Staudt LM, McDermott U, Brenton JD, McNeish IA, Biankin A, Sansom OJ, Cortes-Ciriano I, Underwood TJ, Fitzgerald RC, Beggs AD, Francies HE, Garnett MJ.   +89 more
europepmc   +1 more source

Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma. [PDF]

J Cancer Res Clin Oncol
Xin X, Lu J, Zhang X, Zhang J, Li Y, Xu X, Li J, Gong L, Lu Q.   +8 more
europepmc   +1 more source

Integrative Multi-Omics and Pan-Cancer Analyses Identify CCL20 as a Prognostic Biomarker with Therapeutic Relevance in Esophageal Cancer. [PDF]

Biomedicines
Guo S, Chen X, Wei M, Yang F, Jiang S, Zhao L, Hu L, Li Z, Shen X.   +8 more
europepmc   +1 more source

Beyond Koch's postulates: the pathobiome paradigm in grapevine esca disease. [PDF]

FEMS Microbiol Ecol
Gramaje D, Eichmeier A.
europepmc   +1 more source

Unveiling the mycobiome of healthy and Esca diseased grapevines: fungal community dynamics across different microhabitats, seasons, years, and cultivars. [PDF]

Environ Microbiome
Geiger A, Leal CM, Karácsony Z, Golen R, Lepres LA, Molnár A, Váczy KZ, Geml J.   +7 more
europepmc   +1 more source